XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.25.1

OTHER INVESTMENTS | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value Disclosures [Abstract] |
OTHER INVESTMENTS | OTHER INVESTMENTS At March 31, 2025, the breakdown of the Company’s other investments was as follows:
|  | Cost |  | Unrealized gains |  | Unrealized losses |  | Accrued interest |  | Fair value / carrying value
Private investments and unlisted equities |  | $ | 28,111 |  |  | $ | 51,559 |  |  | $ | (7,697) |  |  | $ | — |  |  | $ | 71,973 |
Debt and convertible debt securities |  | 2,713 |  |  | — |  |  | (1,510) |  |  | 90 |  |  | 1,293 |
Total other investments |  | $ | 30,824 |  |  | $ | 51,559 |  |  | $ | (9,207) |  |  | $ | 90 |  |  | $ | 73,266 |
At December 31, 2024, the breakdown of the Company’s other investments was as follows:
|  | Cost |  | Unrealized gains |  | Unrealized losses |  | Accrued interest |  | Fair value / carrying value
Private investments and unlisted equities |  | $ | 28,111 |  |  | $ | 51,076 |  |  | $ | (7,320) |  |  | $ | — |  |  | $ | 71,867 |
Debt and convertible debt securities |  | 2,713 |  |  | — |  |  | (1,510) |  |  | 90 |  |  | 1,293 |
Total other investments |  | $ | 30,824 |  |  | $ | 51,076 |  |  | $ | (8,830) |  |  | $ | 90 |  |  | $ | 73,160 |
The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at March 31, 2025 and 2024, and the related adjustments recorded during the periods then ended.
|  | Three months ended March 31
|  | 2025 |  | 2024
Carrying value (1) |  | $ | 71,973 |  |  | $ | 71,577 |
Upward carrying value changes (2) |  | $ | 483 |  |  | $ | 419 |
Downward carrying value changes and impairment (3) |  | $ | (377) |  |  | $ | (114) |
(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes. (2) The cumulative upward carrying value changes from inception to March 31, 2025, totaled $54.0 million. (3) The cumulative downward carrying value changes and impairments from inception to March 31, 2025, totaled $10.1 million. Net investment income The following table summarizes the change in unrealized gains (losses) and the realized gains (losses) for the Company’s other investments, which are included in “Net investment income” in the condensed consolidated statements of operations (see Note 13):
|  | Three months ended March 31
|  | 2025 |  | 2024
Gross realized gains |  | $ | 5 |  |  | $ | — |
Gross realized losses |  | — |  |  | (1,332) |
Net realized gains (losses) |  | $ | 5 |  |  | $ | (1,332) |
Change in unrealized gains |  | 106 |  |  | 919 |
Net realized and unrealized gains (losses) on other investments |  | $ | 111 |  |  | $ | (413) |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration